These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25818893)

  • 21. In-depth analysis of the critical genes and pathways in colorectal cancer.
    Liu F; Ji F; Ji Y; Jiang Y; Sun X; Lu Y; Zhang L; Han Y; Liu X
    Int J Mol Med; 2015 Oct; 36(4):923-30. PubMed ID: 26239303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the mechanism underlying the therapeutic effects of butein in colorectal cancer using network pharmacology and single-cell RNA sequencing data.
    Lu Y; Shan L; Cheng X; Zhu XL
    J Gene Med; 2024 Jan; 26(1):e3628. PubMed ID: 37963584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
    Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
    ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the mechanism of Tengli Kangliu Decoction in the prevention and treatment of colorectal cancer precancerous based on network pharmacology.
    Liu F; Cao B; Zhang H; Zou Q; Liu G; Dong Y; Su D; Ren DL
    Medicine (Baltimore); 2022 Nov; 101(46):e31690. PubMed ID: 36401413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.
    Wen Q; Dunne PD; O'Reilly PG; Li G; Bjourson AJ; McArt DG; Hamilton PW; Zhang SD
    Oncotarget; 2017 Jan; 8(2):3206-3225. PubMed ID: 27965461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data.
    Manoochehri H; Jalali A; Tanzadehpanah H; Taherkhani A; Saidijam M
    J Gastrointest Cancer; 2022 Sep; 53(3):649-668. PubMed ID: 34432208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
    Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
    Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells.
    Lee JG; McKinney KQ; Pavlopoulos AJ; Park JH; Hwang S
    J Proteomics; 2015 Jan; 113():326-36. PubMed ID: 25451013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
    Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
    Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and analysis of the molecular targets of statins in colorectal cancer.
    Firouzjaei AA; Mahmoudi A; Almahmeed W; Teng Y; Kesharwani P; Sahebkar A
    Pathol Res Pract; 2024 Apr; 256():155258. PubMed ID: 38522123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
    Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the pharmacological and molecular mechanisms of Salvia chinensis Benth in colorectal cancer: A network pharmacology and molecular docking study.
    Zheng Q; Wang X; Gao T; Zhang B; Zhao N; Du R; Zhao Z
    Medicine (Baltimore); 2023 Dec; 102(50):e36602. PubMed ID: 38115259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
    Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
    Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
    Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
    Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
    World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
    Sønderstrup IM; Nygård SB; Poulsen TS; Linnemann D; Stenvang J; Nielsen HJ; Bartek J; Brünner N; Nørgaard P; Riis L
    Mol Oncol; 2015 Jun; 9(6):1207-17. PubMed ID: 25777966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.